<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058632</identifier>
<setSpec>1134-3230</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Peripheral vascular disease evaluation in patients with type 2 diabetes by measurement of ankle-brachial index</dc:title>
<dc:description xml:lang="en">Objectives: To report the results of ankle-brachial index (ABI)        measurement in patients with type 2 diabetes evaluated in a Diabetes        Care Unit. Patients and methods: A descriptive study was        performed between 2005 and 2006 in patients with type 2 diabetes        by measuring the ABI with bidirectional echo-Doppler. The results        and their relationship to demographic, clinical and analytical variables        were analyzed. An ABI of 0.9 or less was considered to be indicative        of disease. Results: The results of 79 examinations carried out in        patients (54.4% women) aged 64.4 ± 9.7 years with a duration of        diabetes of 13.9 ± 8.1 years were analyzed. The ABI was normal in        67.1% of the patients and indicative of disease in 32.9%. Twentyfive        of the patients in the latter group had normal peripheral pulses        and 34.6% reported no symptoms. Patients with an ABI indicative of        disease were older (68 ± 8.6 versus 62.7 ± 9.9 years old; p=        0.016), more often were men (47% versus 20.9%; p= 0.013) and        smokers (45% versus 24%; p= 0.044), presented lower LDL-cholesterol        levels (100.8 ± 32.6 versus 118.7 ± 35.7 mg/dl; p=        0.039) and more frequently were taking aspirin (47.2% versus        21.4%; p= 0.016) than patients with normal ABI. Conclusions:        Peripheral vascular disease screening by measurement of ABI should        be recommended in all type 2 diabetes patients because it enables        the identification of asymptomatic peripheral vascular disease in the        absence of disease symptoms or examination findings</dc:description>
<dc:creator>Roca, M. M</dc:creator>
<dc:creator>Baena, G</dc:creator>
<dc:creator>Aguilar, M</dc:creator>
<dc:creator>Carral, F</dc:creator>
<dc:creator>Sánchez, C</dc:creator>
<dc:creator>Valencia, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Describir los resultados de la medición del índice tobillobrazo        (ITB) en pacientes con diabetes tipo 2 (DM2) evaluados en        una unidad de atención especializada. Pacientes y métodos: Estudio        descriptivo realizado en pacientes con DM2 en los que se valoró        el ITB mediante ecografía Doppler bidireccional durante los        años 2005 y 2006. Se analizan los resultados obtenidos y su relación        con diversas variables demográficas, clínicas y analíticas. Se        consideró patológico un ITB igual o inferior a 0,9. Resultados: Se        analizan 79 exploraciones en pacientes de 64,4 ± 9,7 años de        edad y 13,9 ± 8,1 años de evolución de la diabetes (54,4% mujeres).        El ITB resultó normal en el 67,1% y patológico en el 32,9%. El        25% de los pacientes con ITB patológico presentaban pulsos periféricos        normales, y el 34,6% no refería síntomas. Los pacientes con        ITB patológico eran de mayor edad (68 ± 8,6 años frente a 62,7 ±        9,9 años; p= 0,016), más frecuentemente varones (47% frente a        20,9%; p= 0,013) y fumadores (45% frente a 24%; p= 0,044), presentaban        niveles más bajos de colesterol LDL (100,8 ± 32,6 mg/dL        frente a 118,7 ± 35,7 mg/dL; p= 0,039) y tomaban más frecuentemente        ácido acetilsalicílico (47,2% frente a 21,4%; p= 0,016).        Conclusiones: El cribado de la enfermedad vascular periférica mediante        medición del ITB debe generalizarse a todas las personas con        DM2, ya que permite identificar la presencia de enfermedad vascular        periférica silente (sin síntomas ni hallazgos exploratorios patológicos)</dc:description>
<dc:source>Av. diabetol;23(5): 370-374, sept.-oct. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-058632</dc:identifier>
<dc:title xml:lang="es">Evaluación de la enfermedad vascular periférica en pacientes con diabetes tipo 2 mediante medición del índice tobillo-brazo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3946^s22012</dc:subject>
<dc:subject>^d29897^s29166</dc:subject>
<dc:subject>^d3948^s22016</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d1136</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d856</dc:subject>
<dc:subject>^d28571</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
